CÁPITULO II: MARCO TEÓRICO 2.1 La Comunicación
2.2.2 Etnocentrismo, Relativismo y Dominación Cultural
At present the RIKTA®is one of the very few medical devices having such a wide spectrum of indications and applications.
IInnddiiccaattiioonnss
1. Some infectious and parasitic diseases.
2. Diseases of endocrine system.
3. Diseases of nervous system.
4. Diseases of eye and surrounding tissue including sinuses.
5. Diseases of ears and mastoid bones.
6. Diseases of circulatory system.
7. Diseases of respiratory organs.
8. Diseases of digestive organs.
9. Diseases of skin and cellular tissue.
10. Diseases of musculoskeletal system and connective tissue.
11. Diseases of urogenital system.
12. Postpartum period problems.
13. Traumas and some other consequences of injury.
Recently the device has found application in cosmetology and sports medicine.
To identify the disease you wish to treat, see the index at the pages 9, 10.
The list of conditions suitable for quantum therapy with the RIKTA®is exceptionally wide which means that this instrument is useful for a wide range of specialists and therapist of all kinds including veterinarian. Yet the device is very simple to use and can at the same time treat both organs and tissues.
C
Coonnttrraaiinnddiiccaattiioonnss
It is important to recognize the areas where this treatment should either not be used or used with caution. These contraindications will also be influen
ced by the condition of the person, compatibility with the treatment and other peculiarities which may arise. While the quantum therapy using the RIKTA®has a very low profile of side effects nevertheless the experience of the practitioners is important to prevent any complications and to obtain maximum effectiveness of the treatment.
Contraindications to RIKTA®device therapy for home use include acute diseases which may cause irreversible structural changes in the body and requi
re urgent medical or surgical management. The list includes some diseases which have not yet been researched for RIKTA®treatment. If other concomitant diseas
es are present (endocrine, tumours) then one should consult with the doctor on whether quantum medical treatment is appropriate.
The basic contraindications to quantum medical treatment
·· thirddegree essential hypertension;
··
·· strokes;
··
·· acute form of hypotonia(low blood pressure);
··
·· malignant neoplasm’s;
··
·· blood diseases;
··
·· insufficiency of the circulation of the blood, II and III stages;
··
·· mental diseases requiring specialist treatment;
··
·· cardiovascular diseases at the decompensatory stage.
A
·· fever (body temperature higher than 38°С);
··
·· hemorrhages and bleeding tendency;
··
·· grave condition of the patient;
··
·· inflammatory process in abdominal cavity and female pelvic area;
··
·· acute surgical pathology requiring operative intervention;
··
·· early post infarction period;
··
·· artificial pacemakers;
··
·· disorders of cerebral circulation (acute condition);
··
·· acute debility of the body ;
··
·· renal/hepatic failure.
S
Soommee aaddvviiccee ttoo aa ppaattiieenntt uunnddeerrggooiinngg tthhee ccoouurrssee ooff ttrreeaattmmeenntt
It is important to follow the advice in the manual in order to obtain opti
mum effects.
1. When treating sit comfortably in an armchair or lie on a flat surface and put a pillow under the lower part of the body. It is best to apply the treatment directly on the skin surface therefore remove the necessary clothing in the area of treatment. It is highly desirable to avoid direct sunlight or bright artificial light in the treatment room.
2. The optimum time for treating chronic disease is in the morning befo
re midday while acute inflammatory disease should be treated after midday. One should try to repeat the treatment at about the same time.
After the treatment it is necessary to have 15 – 20 minute rest.
3. During the treatment the patient must keep to a diet which excludes spicy dishes and dishes with a sharp taste and eat more fresh fruit and vegetables.
It is very important to drink adequate water which can include mineral water, fruit jui
ces and herb teas. A minimum of 1.5 litres per day is adequate for most people.
4. The quantum therapy program has a number of different stages:
a. Introductory stage: This is the early phase of treatment when no chan
ge is apparent and yet the body has accepted the quantum treatment and has already begun a healing process. The healing is occurring at a deep level and there is no change in the symptoms yet. Don’t be surprised however if already after the first treatment there is a shift in the symptoms. This may however last only hours or a day or two after the first few treatments. Deep seated chronic organ diseas
es however will require much more treatment. The introductory phase of treat
ment may consist of 2 to 10 treatment sessions. The number of sessions will depend on the patients health and response to treatment. Some conditions as indicated may respond dramatically even after only 2 or 3 treatments especially problems of muscles and connective tissues. Internal organ treatment will requi
re longer and more treatments.
b. Therapeutic stage: This follows the introductory stage and may begin after 3 or 4 treatment in the case of muscular and connective tissue problems or take much longer with internal organ diseases. This stage may consist of 5 to 15 sessions and will follow after the introductory stage.
c. Conclusive stage: It is useful to follow the therapeutic stage with further treatments 3 to 4 weeks later in order to consolidate the treatment.
d.Prophylactic course: Some people do really well if they have a repeated course of treatment 3 to 4 times per year. This can be regarded as ‘booster’ tre
atments and may prevent further deterioration of the condition.
5. If there is an exacerbation of symptoms after 3 to 4 treatments then it is essential to shorten the time of treatment as recommended in the manual for that condition or to leave a day free between treatments. As a rule exacerbations are regarded as a positive sign and don’t last for longer than 48 hours.
To prevent exacerbations it is recommended that the following supple
ments should be taken:
Vitamin A, E (tocopherol) and C (ascorbic acid) – 300 mg, ginseng tinctu
re and a good quality antioxidant. These should also be taken before each thera
peutic session.
6. The therapeutic sessions should always follow the recommendations outlined in the manual.
The treatment sessions should not stop immediately after the symptoms and pain disappear. There is still healing work that must be complete even when the symptoms have disappeared.
7. The treatment program should not be longer than that recommended in the manual.
The duration of a session must not exceed 3540 minutes.
8. Two diseases may not be treated simultaneously even if there are improvements.
9. If there is insufficient or no response to treatment then the course of treatment can be repeated after a break of a month or two.
10. The recommended power of application depends on the patient’s age:
for newborn children the power is set on the level 25%, for children under 14 and the elderly it should be set at 50%. Treating children 14 or older and adults 100% power is used
11. Caution! Do not allow direct radiation into the eyes!
D
Diiffffeerreenntt mmeetthhooddss aanndd pprriinncciipplleess ooff aarreeaa cchhooiiccee..
In treating with the RIKTA®medical device different methods are used depending on the disease, body area and patients age.
The method used can be divided into following groups:
1. contact;
2. distant;
3. stable;
4. scanning;
5. combined.
1. The contact method: the hand held applicator is placed in full contact with the area to be treated.
2. The distant (noncontact) method: the hand applicator is held some distance away from the area to be treated. This can vary between 0.53cm.
3. The stable method: the applicator is in a fixed position over the area to be treated.
4. The scanning method: this method is used when a wide area must be trea
ted. In this case the applicator is moved in the appropriate direction at a speed of 0.5 to 1.5 cm per second (forward backwards, to the left – to the right, upward downward).
5. The combined method: the various methods described above are used together depending on the requirements.
M
Maaiinn pprriinncciipplleess iinn ddeevveellooppiinngg tthhee ttrreeaattmmeenntt pprrooggrraamm
In choosing the area to treat one should always be aware of the body’s constitution, the homeostatic regulatory mechanisms within the body and the res
ponse of the body to the ill health and disease.
1. Direct application over the lesion on the skin (trophic ulcer, hydradeni
tis etc) , mucous membrane (tonsillitis, cervical erosion etc), frontal projection over organs where there is pathology (lungs, stomach etc). Direct application over the pathology may be combined with points along the spinal column (paraveteb
ral points) which connect and influence the organs and tissues being treated in a segmental way. (Fig. 1). Other points on the body may also be treated which con
nect the diseased area in reflex ways through the various multilevel nervous con
nections of nervous regulation.
Eye Lachrymal gland
Schneiderian membrane (nasal mucosa) Submandibular gland
Sublingual gland Mucous membrane of mouth Parotid gland
Cerebrum, spinal cord and vegetative nervous system, segmental nervous areas.
2
2.. Areas of general regulatory effects:
Hormone status (areas of adrenal glands, ovaries), Fig. 2, and the areas of the prostate gland (the perineum between the anus and root of penis closer to the anus);
Area of ovaries Area of adrenal glands
F Fiig g.. 2 2
(a) (b)
Antiallergenic areas (areas of adrenal glands, frontal projection of liver, pancreas and intestines), Fig. 2; Fig. 3;
Areas of intestines:
1. Right iliac region.
2. Projections of hepatic angle of large intestine.
3. Projection of splenic angle of large intestine.
4. Left iliac region.
(а)
(b)
(c) Area of frontal hepatic projection
Area of frontal projection of pancreas
Area of frontal hepatic projection
1 1 2
2 33
4 4
F
Fiig g.. 3 3
Area of the cervical vertebra prominence
Areas of great vessels (fig. 4) and projection of heart area (the fourth intercostal space on the left side of the sternum)
Ulna artery Axillary artery
Femoral artery Clavicular arteries Carotid artery
The fourth intercostal space on the left side of the sternum
F
Fiig g.. 4 4
3
3.. Specific areas (Fig. 5; Fig. 6) T
Thheerree aarree ssppeecciiffiicc aarreeaass aanndd iinnfflluueenncceess wwhhiicchh mmaayy bbee ooff ssppeecciiaall iinntteerreesstt ttoo ddooccttoorrss aanndd ootthheerr tthheerraappiisstt wwhhoo mmaayy wwiisshh ttoo ggoo ddeeeeppeerr iinnttoo tthhee qquuaannttuumm m
meetthhooddoollooggyy..
The specific areas are ZaharjinHead’s zones and socalled trigger zones, as shown at the Fig.5 and 6.
ZaharjinHead’s zones are areas of skin surface which are hypersensiti
ve and even supersensitive to pain ( hyperesthesia) and are often associated with organ diseases (liver, kidney etc). These zones are a special case of the trigger zones described below.
Trigger zones are areas of hyperactivity which appear usually on the skin, in muscles but also joint capsules, ligaments, periosteum , skin and scars.
They can show up as skin (in medicine it is “extraceptive”) trigger zones, muscular fasciocutaneous tendinous (a medical term “proprioceptive”) trigger zones and trigger zones of viscera (intraceptive).]
The skin (extraceptive) trigger zones may appear as focal thickening (indu
rations ), gooseflesh, reddening, blanching or desquamation of the skin.
Muscular fasciocutaneous tendinous (proprioceptive) trigger zones are detected (palpated) or tapped (percussed) as parts of maximum pain sensitivity (such as ZaharjinHead’s zones) or local muscular fasciocutaneous indurations (thickenings).
The diagnosis of intraceptive trigger zones can cause difficulties; they often are presented as skin or muscular fasciocutaneous tendinous zones (or Zaharjin
Head’s zones).
The trigger zones may become more activated (or active) in the presence of some inner diseases. In other words they may represent important signs of organ disease. They can also be used as communication channels, through which the therapist can influence the diseased organ.
The triggers zones can be found in the direct projection of an organ or far away from it, along referred channels which may follow spinal segmental patterns.
These trigger zones therefore have important therapeutic possibilities and also are of diagnostic value.
When we influence these manifested trigger zones with all the possible components of the device, we realize and experience the principle of feedback because a physical organ is connected with a physical trigger zone and vice versa, and the diseased organ is connected with a manifested trigger zone. So the trig
ger zones provide indirectly more accurate orientation and individualization of the medical treatment through these bioenergicinformational zones.
IIff tthhee ttrriiggggeerr zzoonneess aarree nnoott mmaanniiffeesstteedd,, oonnee sshhoouulldd nnoott ttrreeaatt tthheessee zzoonneess..
T
Thhee ffrreeqquueennccyy rraannggee ooff qquuaannttuumm tthheerraappyy uuppoonn ttrriiggggeerr zzoonneess::
extraceptive trigger zones: 1000 Hz (with the exception of the frontal heart projection);
proprioceptive, introceptive trigger zones: 50 Hz, 5 Hz or “Variable”.
The criteria for the duration of a quantum medical treatment on trigger zones is the decrease or abolition of the symptoms corresponding to the area being trea
ted (on average 25 minutes). The method used (stable or scanning) to influence the trigger zones will depend on the extent to which the symptoms have spread. As a general rule it is better not to move the emitter too fast over the surface.
Liver,
Trigger zones of the front sur
face of the body (the areas of pain sensation and skin hype
resthesia of ZaharjinHead) for cardiovascular and bronchopulmonary systems.
F
Fiig g.. 5 5
Coronary vessels, heart, aorta
Pancreas (Calk’s area)
Lung, bronchus
Liver, gallbladder
Spleen
Pancreas, sto
mach
Urogenital organs
Urinary bladder
Trigger zones of the back surface of the body (the areas of pain sensation and skin hyperesthesia of ZaharjinHead) for cardiovascular and bronchopulmonary systems.
Uterus